Key Events This Week
15 Jun: Golden Cross formation signals potential bullish breakout
17 Jun: Technical momentum shifts bullish amid mixed signals
18 Jun: Valuation shifts from very expensive to expensive
19 Jun: Week closes at Rs.962.95 (-2.77%)
Jun 23, 03:30 PM
BSE+NSE Vol: 10.9 lacs
15 Jun: Golden Cross formation signals potential bullish breakout
17 Jun: Technical momentum shifts bullish amid mixed signals
18 Jun: Valuation shifts from very expensive to expensive
19 Jun: Week closes at Rs.962.95 (-2.77%)

Fortis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Fortis Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive category, reflecting evolving market perceptions. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to assess the stock’s price attractiveness.
Read full news article
Fortis Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend across key indicators. This transition, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, suggests a cautiously optimistic outlook for the hospital sector mid-cap stock amid mixed market conditions.
Read full news article
The 50-day moving average has crossed above the 200-day moving average for Fortis Healthcare Ltd, signalling a golden cross on 15 Jun 2026. Yet, the stock declined 1.04% on the day this crossover occurred, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the technical and fundamental backdrop to assess the reliability of this widely watched event.
Read full news article
8 June: Surge in call option activity and open interest amid bullish momentum
8 June: Valuation shifts to very expensive with elevated P/E and P/B ratios
9 June: MarketsMOJO upgrades rating from Sell to Hold on technical and valuation shifts
9 June: Technical momentum shifts signal mildly bullish outlook
12 June: Stock closes the week at Rs.990.40, outperforming Sensex

Fortis Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and valuation metrics despite flat recent financial performance. The mid-cap hospital sector stock’s improved technical indicators and sustained long-term returns have prompted a reassessment, although valuation concerns remain elevated.
Read full news article
Fortis Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in the hospital sector mid-cap stock.
Read full news article
Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, coinciding with a strong upward price momentum. The stock has outperformed its sector and broader indices, reflecting increased market participation and evolving positioning among traders and investors.
Read full news articleThe Intimation is regarding an update on the Income Tax Order received by Fortis Hospitals Limited (Wholly Owned Subsidiary of the Company)
The relevant disclosure is attached.
Relevant disclosure attached
No Upcoming Board Meetings
Fortis Healthcare Ltd has declared 10% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
Fortis Healthcare Ltd has announced 2:5 rights issue, ex-date: 18 Aug 09